Age and the risk of resistant pathogens

Starting to read the February Antimicrobial Resistance Benchmark (https://accesstomedicinefoundation.org/publications/2019-methodology-for-the-2020-antimicrobial-resistance-benchmark) the following citation directly hits me: “In recent decades, AMR has become widespread, irrespective of national income levels. In Europe, drug-resistant bacteria are responsible for more than 670,000 infections and 33,000 deaths annually, costing EUR 1 billion in annual healthcare expenditure. Each year in the US, […]

Read more